Basics Sight Sciences, Inc. Common Stock IPO Date: July 12, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $201.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 3.66% Avg Daily Range (30 D): $0.09 | 2.75% Avg Daily Range (90 D): $0.11 | 3.91% Institutional Daily Volume Avg Daily Volume: .21M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 88 Avg Trade Size (Sh.) (90 D): 95 Institutional Trades Total Inst.Trades: 120 Avg Inst. Trade: $2.35M Avg Inst. Trade (30 D): $.54M Avg Inst. Trade (90 D): $.54M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.63M Avg Closing Trade (30 D): $.54M Avg Closing Trade (90 D): $.54M Avg Closing Volume: 260.34K     News Feb 10, 2025 @ 3:00 PM Dry Eye Treatment Devices Market Poised to Attain ... Source: Astute Analytica Jul 18, 2024 @ 8:06 PM Sight Sciences to Report Second Quarter Financial ... Source: N/A Jul 4, 2024 @ 12:01 AM Sight Sciences CFO Alison Bauerlein sells over $65... Source: Investing.Com Jun 10, 2024 @ 8:05 PM Sight Sciences Announces the Release of its First ... Source: Sight Sciences, Inc. May 28, 2024 @ 8:05 PM Sight Sciences Announces the Publication of Twelve... Source: Sight Sciences, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.28 $-.24 $-1.03 Diluted EPS $-.28 $-.24 $-1.03 Revenue $ 17.51M $ 19.07M $ 79.87M Gross Profit $ 15.09M $ 16.56M $ 68.29M Net Income / Loss $ -14.15M $ -11.85M $ -51.51M Operating Income / Loss $ -13.86M $ -11.93M $ -50.53M Cost of Revenue $ 2.41M $ 2.51M $ 11.58M Net Cash Flow $ M $ 1.79M $ -17.77M PE Ratio